PRESENTS 3RD PARTNERING WITH

SUMMIT

MARCH 18–19, 2014

THE INN AT PENN,

A HILTON HOTEL

PHILADELPHIA, PA

LEARNING OBJECTIVES:

■ Gain a better understanding of the accountable care marketplace and how the healthcare delivery system is changing for millions of patients

■ Explore why a standard sales platform needs to be shifted into a non-commercial value-based partnership strategies when interacting with ACOs

■ Hear directly from ACO executives on what they are looking for from anindustry partner and how these partnerships can assist them in meeting CMS quality measurements

■ Discover ways to develop value-based programs that would enhance effi ciencies, improve patient outcomes, increase patient adherence, or improve quality of care

■ Discover best practices and case studies on how to develop and implement a successful cross industry partnership

TODD BERNER ASTELLAS

ROBERT BRENNER SUMMIT MEDICAL GROUP

MARK FULCO SISTERS OF PROVIDENCE HEALTH SYSTEMS

KITTY RAJAGOPALAN SUNOVION

BRENDA RADKE MEDICAL PRACTITIONERS FOR AFFORDABLE CARE

PAM BAKER CARDIODX

Don’t Miss The Relationship with ACO Board Room Dinner on Tues-day March 18th at 6:00pm

Identifying New Platforms, Tools, and Strategies to

Assist Accountable Care Organizations in Reducing Costs,

Improving Quality, and Increasing a Populations Care

While Developing a Benefi cial Cross-Industry Relationship

Industry Leaders Representing:

AMGEN

ARIZONA SUN

ASTELLAS

BAYER

BREVARD PHYSICIAN NETWORK

BRISTOL-MYERS SQUIBB

CARDIODX

CATHOLIC MEDICAL PARTNERS

COOPER UNIVERSITY HOSPITAL

DURATA THERAPEUTICS

FLORIDA PHYSICIANS TRUST ACOS

GOLDENLIFE HEALTHCARE

HUNTERDON HEALTHCARE PARTNERS

MARTIN HEALTH SYSTEM

MEDICAL PRACTITIONERS FOR AFFORDABLE CARE

OTSUKA

PFIZER

SISTERS OF PROVIDENCE HEALTH SYSTEMS

SUNOVION

VERTEX PHARMACEUTICALS

WALGREENS

WEST FLORIDA ACO LLC

SPONSORED BY

INN AT PENN, A HILTON HOTEL3600 Sansom Street, Philadelphia, PA 19104

Stay at The Inn at Penn, A Hilton Hotel; an AAA Four Diamond hotel situated in the heart of the University of Pennsylvania verdant, tree-lined campus. Enjoy beautifully-appointed Ivy League accommodations in the culturally rich and diverse neighborhood of University City, within easy walking distance of some of the nation’s most prestigious medical, educational and corporate centers. Dine in style at the award-winning Penne Restaurant & Wine Bar, unwind in the Living Room Lounge, or maintain your fi tness regime in our 24-hour fi tness center.

To make reservations please call 215-222-0200 and request the negotiated rate for ExL’s 3rd ACOs. You may also visit: http://www.hilton.com/en/hi/groups/personalized/P/PHLIDHH-3RDP-20140317/index.jhtml to make reservations online.

The group rate is available until February 24, 2014. Please book your room early as rooms available at this rate are limited

WHO SHOULD ATTEND

LIFE SCIENCES INDUSTRY

■ Pricing & Reimbursement, Health Economics & Outcomes Research

■ Account Management

■ Brand/Product Management

■ Organized/Managed Markets

■ Sales & Marketing

■ Medical Affairs, Medical Science Liaisons, Scientifi c Account Liaison

■ Policy, Government Affairs

■ Managed Care

■ Evidence Based Medicine Team Leaders

ACOs, HEALTH PLANS AND PHYSICIAN ORGANIZATIONS■ Executive Leadership

■ Chief Medical Offi cers

■ Medical Directors

■ Quality and Care Directors

■ Administrators

■ Medicaid Managed Care Directors

Dear Colleague,

As the creator of The Partnering with ACO series I would like to invite you to our 3rd

Partnering with ACO Summit this March 2014 in Philadelphia, PA. This year’s meeting is

designed as an educational platform that will allow the life science industry to explore

the best practices in engaging with ACOs while developing a benefi cial cross-industry

relationship.

As an industry we have been challenged to adapt to changes including new markets,

regulations, product launches, and currently we are adapting our customer facing

approach to Accountable Care Organizations. With the rapid growth of nearly 400+

ACOs currently operating in the US, industry is undergoing changes to assist these

value-based healthcare systems. As a value-based healthcare system, ACOs are

always looking for innovative platforms, services, and products that can assist them

in increasing patient care, improving quality, increasing a population’s care and in turn

allowing them to share in the cost savings.

With the success of ACOs, it’s clear that industry needs to prepare for growth and

change over the next few years. Success in this new healthcare delivery model results in

how prepared an organization is in being able to alter from a standard sales approach to

a non-commercial value-add partnership. The outcome of these partnership strategies

is not only a strong relationship with an ACO, but a profi table revenue stream for a

manufacturer.

Currently some of the partnership platforms include data exchanges, health economics

outcomes research, patient engagement, and many more. As these partnerships

continue to develop, we are learning that it’s much more than developing a partnership

platform. It’s about learning and understanding your customer in order to engage with

them while demonstrating the value you can provide in meeting their goals.

Returning for its second year the ACO Relationship Board Room Dinner will provide

industry leaders with an intimate networking opportunity to hear from ACO executives

on what they are looking for from manufacturers.

I look forward to seeing you in Philadelphia, PA this March!

Sincerely,

Scott Grossman

Director, Partnering with ACO Series

5 10 15 20 25

Life Science Attendee Profiles

Profiles Represented in Percentage

Pricing, Reimbursement, Health Economics Outcomes Research

Account Managers

Organized/Managed Markets

Sales and Marketing

Brand/Product Management

Policy/ Government

Medical Affairs

Pharmaceutical

Medical Device

Accountable Care Organizations

Biotechnology

Laboratory

Service Providers

5 10 15 20 25

Company Profiles

Profiles Represented in Percentage

TO REGISTER: Call 866-207-6528 or visitWWW.EXLPHARMA.COM/ACO

DAY ONE | TUESDAY MARCH 18, 2014 8:00 REGISTRATION AND CONTINENTAL BREAKFAST

8:45 OPENING REMARKSTODD BERNER, MD, Director, Urology Health, Economics and Clinical Outcomes Research, Urology, ASTELLAS SCIENTIFIC AND MEDICAL AFFAIRS, INC.MARK FULCO, Senior Vice President, Strategy and Marketing, SISTERS OF PROVIDENCE HEALTH SYSTEMS

9:00 ACO Executive Perspective: Recognize the Impact on Healthcare Markets, Emerging Trends, and Key Success Factors

■ High level overview on US healthcare system ■ Emerging trends in ACO’s and commercial shared savings ■ Key success factors for managing risk ■ Examples from a large multi-specialty group ■ Opportunity for Q&A and discussion

ROBERT W. BRENNER, MD, MMM, Chief Medical Offi cer, SUMMIT MEDICAL GROUP

9:45 Industry Executive Perspective: Restructuring an Organizational in Order to Develop a Partnership to Working with ACOs though a Systematic Approach

■ Evaluating the best way to engage with ACOs through need-based roadshow type market research interactions

■ Understanding The ACO customer Model and approach to drug management or formulary

■ Developing tools and tactics that fi t ACO customer needs and manufacturers interests.

■ Incorporating clinical marketing, pharmaeconomics, observational research, and other stakeholders to develop a value-based communication approach

LAURENT CARTER, Executive Director Payer Segment & Value Marketing US Value and Access, AMGEN

10:30 Manufactures Role: Understanding the Important Role in the Uptake and Utilization of Emerging Models that Stakeholders Play in the ACO Landscape

■ Understanding where manufactures fi t in as a key stakeholder in the ACO environment

■ Opportunities for innovative partnerships and new evidence generation

■ Involvement in education and awareness of value ■ Demonstrating how products and services improve clinical

outcomes through HEOR-based studies

Session Presented by XCENDA

11:00 NETWORKING BREAK

11:30 PARTNERSHIP CASE STUDY | Working Together to Achieve Triple Aim

■ Merging the healthcare and industry perspective together to enable better care at less cost

■ Communication and demonstrating the value in an innovative diagnostic tests, devices and therapeutics that can assist increasing care

■ Overview of the partnership built based off of shared interests between a life science organizations and an ACO

■ Success of the partnership and impact on patient care and ACO quality

PAM BAKER, Senior Director, Market Access, CARDIODXRAKESH PATEL, MD, Owner, ARIZONA SUN FAMILY MEDICINE, PC

“This summit gave me a new way of looking at the ACO

marketing place” —DIRECTOR, HEALTH POINT

12:15 Accountable Care Organizations: What are the Opportunities and Risks Within This Emerging Customer Segment?

Overview of emerging trends in Medicare, Medicaid, and commercial ACOs and the impact of ACOs on product, portfolio, and company as well as how ACO impact will vary across therapeutic categories.

■ What do risk arrangements look like across ACO types in various segments?

■ Who are the decision makers in these developing models?

■ What are ACO goals for disease management in the nascent years of development?

■ What strategies should industry develop to create collaborative relationships with ACOs

BOB SHEWBROOKS, Principal, Practice Leader, HEATH STRATEGIES GROUP

1:00 LUNCHEON

2:00 Improving Outcomes: Data Sharing with Life Science to Improve Clinical Care

■ Designing and implementing a data sharing platform

■ Innovative strategies for delivering the best possible care

■ Utilizing comparative effective research to successfully demonstrate a products value

■ Understanding how data partnerships can transform healthcare delivery within an ACO

■ Emphasizing on evidence-based care and on managing a population to a set of general costs and quality outcomes

KITTY RAJAGOPLAN, Vice President, Health Economics Outcomes Research, SUNOVION

2:45 Heath Economics Outcomes Research: Collaborating with ACOs to Improve Patient Data

■ New insights into the process of research evidence generation in support of value-based performance improvement for to increase the value of your product

■ Learn the benefi ts of assembling a multi-stakeholder collaboration based on HEOR data to improve population health, patient’s experience of care, and per capita costs

■ Construct and implement a predictive market access model for the planned intervention utilizing evidence generated through the collaborative research process

■ Explore best practices for assessing, disseminating, and applying the research collaboration generated evidence to ensure the advancement of successful of patient centered outcomes

TODD BERNER, MD, Director, Urology Health, Economics and Clinical Outcomes Research, Urology, ASTELLAS SCIENTIFIC AND MEDICAL AFFAIRS, INC.

3:30 NETWORKING BREAK

4:00 Supporting an ACO: Developing a Unifi ed Organizational Strategy to Successfully Implement Strategic Collaborations

■ Segmenting the marketplace and understanding what ACOs require from industry

■ Educating an organization on the need for a unifi ed approach to collaborate with ACOs

■ Established an companywide defi nition of an ACO ■ Understanding the contracting element to partnering with ACOs ■ Developing a non-branded disease state education platforms

with medical regulations and medical communication approval ■ Implementing your strategic approach to ACOs

ANDREW ERICKSON, MBA, Innovative Market Team Director, BAYER HEALTHCARE PHARMACEUTICALS

4:45 CO-CHAIRS CLOSING REMARKS

5:00 DAY ONE CONCLUDES

TO REGISTER: Call 866-207-6528 or visitWWW.EXLPHARMA.COM/ACO

DAY TWO | WEDNESDAY MARCH 19, 2014

8:00 REGISTRATION AND CONTINENTAL BREAKFAST

9:00 DAY ONE RECAP TODD BERNER, MD, Director, Urology Health, Economics and Clinical Outcomes Research, Urology, ASTELLAS SCIENTIFIC AND MEDICAL AFFAIRS, INC.MARK FULCO, Senior Vice President, Strategy and Marketing, SISTERS OF PROVIDENCE HEALTH SYSTEMS

9:15 CASE STUDY | Developing and Launching and Effective Patient Engagement Platform within an ACO

■ Affectively developing a patient engagement platform within an ACO to successful engage patients

■ Discovering ways to engage patients more affectively in healthcare delivery

■ Developing a non-sales engagement structure with industry ■ Working with life science educational divisions to assist in

structuring these platforms ■ Developing adherence arrangement around patient needs

and disease states ■ Allocating resources to fi ll this un-met cost need

BRENDA RADKE, Executive Director, MEDICAL PRACTITIONERS FOR AFFORDABLE CARE

10:00 Impact of a Strategic ACO Pharmacy Program and Its Affect on Patient Care

■ Identifying the pharmacy’s role in accepting responsibility for cost and quality of care

■ Increasing the impact of patient contact ■ Shift from a strict acute-care focus to an ever-greater

emphasis on preventive care ■ Controlling costs and reimbursement pressure ■ Reimbursement structure within an ACO through bundled

payments, captivated arrangements, and shared savings ■ Reallocation of pharmacy resources and talents ■ Pharmacy’s role in cost

DAVID HARLOW, Chief Pharmacy Offi cer, MARTIN HEALTH SYSTEM

10:45 NETWORKING BREAK

11 : 15 Organization Change: Developing a Successful Plan for Partnering with an ACO

■ Understanding the roles and goals of ACOs in the healthcare environment

■ What are the expectations of ACOs ■ How does industry develop strategies to meet the

needs of the ACOs

12:00 LUNCHEON

1:00 ACOs and Bundled Payment Models: The New Reality for Providers and Life Sciences

■ The evolution of payment reform and acceleration of initiatives by public and private payors

■ ACA as a major catalyst for new payment and delivery reform models such as ACOs

■ The shift in focus and incentives for providers in ACOs and bundled payment initiatives

■ The impact of ACOs and the new payment initiatives on the development of value propositions by the Life Sciences

ANDREW THORRENS, Head of Reimbursement and Market Access, DURATA THERAPEUTICS, INC.

1:45 Shifting Communication Approach’s: Understanding and Engaging with your Customers to Expand Partnership Buy-In

■ Understanding your customers: How ACOs see themselves and their mission

■ Exploring the cost savings and patient quality structures ACOs work in

■ Identifying ways to bring value to ACOs ■ Adjusting your support strategies to facilitate your

customers’ goals ■ Developing platforms in which you can demonstrate value

and develop collaborative partnerships that work for both industry and ACOs

LON CASTLE, Medical Science Liaison, CARDIODX

2:30 Navigating the Value-Based Healthcare Environment: Developing an Organization Wide Approach to Understand the Changing Healthcare Delivery System and our Customers

■ Understanding of ACOs and their impact on patient care ■ Developing and gathering market research to develop a fi rm

grasp of the ACO culture ■ Analyzing market research to develop strategies for enhancing

relationships with ACOs ■ Developing customer engagement platforms strategies focused

on strategic value collaboration

LAUREN WALRATH, Director, Business Model Innovation and Commercial Operations, BRISTOL-MYERS SQUIBB

3:15 CLOSING REMARKS

3:30 SUMMIT CONCLUDES

The ACO Relationship Board Room Dinner6:00-9:00 Developing ways to Collaborate and Supply the Healthcare Marketplace

With the rapid growth of ACOs and the increasing number of changes within healthcare system its clear that a traditional sales style will not work for ACOs. Instead, adapting a relationship style of partnering with your customers is now the preferred method, and is well received by ACO executives. By developing these sustainable relationships, manufactures will be able to develop a two-way dialogue where they can construct strategic platforms that will allow ACOs to improve quality, patient care, and improve a populations care.

Some of the most common strategies are designed because ACOs are in need of outcomes data, clinical services, affective diagnostic testing, laboratories services and patient adherence support. However as every ACO is constructed differently there is not one preferred platform to provide value. It’s important for you to understand how your customer is designed, functions, how patients are treated, and what value-add they are requiring.

This exclusive dinner will allow participants the chance to network and start the relationship process with ACOs. The pre-dinner interactive panel session will feature ACO executives discussing the following:

■ Overview of their organization ■ Structure of their ACO ■ Payment models ■ Value-add needs

BOARD ROOM DINNER LEADER: DAVID B. NASH, MD, MBA, Dean, JEFFERSON SCHOOL OF POPULATION HEALTH

ACOs PARTICIPATING INCLUDE:

For additional information go to EXLPHARMA.COM/ACO *Limited seats available

■ How industry can provide value to their ACO

■ Resources needed to execute a successful ACO

Atrius Health Brevard Physician Network Cooper University HospitalGoldenlife HealthcareFlorida Physicians Trust ACOsThe Hackensack Alliance Accountable Care Organization

Health Catalyst/TEAM of Care Solutions Hunterdon Healthcare PartnersMartin Health SystemSisters of Providence Health SystemsSummit Medical GroupWalgreensWest Florida ACO LLC

DAY TWO | WEDNESDAY MARCH 19, 2014

8:00 REGISTRATION AND CONTINENTAL BREAKFAST

9:00 DAY ONE RECAP TODD BERNER, MD, Director, Urology Health, Economics and Clinical Outcomes Research, Urology, ASTELLAS SCIENTIFIC AND MEDICAL AFFAIRS, INC.MARK FULCO, Senior Vice President, Strategy and Marketing, SISTERS OF PROVIDENCE HEALTH SYSTEMS

9:15 CASE STUDY | Developing and Launching and Effective Patient Engagement Platform within an ACO

■ Affectively developing a patient engagement platform within an ACO to successful engage patients

■ Discovering ways to engage patients more affectively in healthcare delivery

■ Developing a non-sales engagement structure with industry ■ Working with life science educational divisions to assist in

structuring these platforms ■ Developing adherence arrangement around patient needs

and disease states ■ Allocating resources to fi ll this un-met cost need

BRENDA RADKE, Executive Director, MEDICAL PRACTITIONERS FOR AFFORDABLE CARE

10:00 Impact of a Strategic ACO Pharmacy Program and Its Affect on Patient Care

■ Identifying the pharmacy’s role in accepting responsibility for cost and quality of care

■ Increasing the impact of patient contact ■ Shift from a strict acute-care focus to an ever-greater

emphasis on preventive care ■ Controlling costs and reimbursement pressure ■ Reimbursement structure within an ACO through bundled

payments, captivated arrangements, and shared savings ■ Reallocation of pharmacy resources and talents ■ Pharmacy’s role in cost

DAVID HARLOW, Chief Pharmacy Offi cer, MARTIN HEALTH SYSTEM

10:45 NETWORKING BREAK

11 : 15 Organization Change: Developing a Successful Plan for Partnering with an ACO

■ Understanding the roles and goals of ACOs in the healthcare environment

■ What are the expectations of ACOs ■ How does industry develop strategies to meet the

needs of the ACOs

12:00 LUNCHEON

1:00 ACOs and Bundled Payment Models: The New Reality for Providers and Life Sciences

■ The evolution of payment reform and acceleration of initiatives by public and private payors

■ ACA as a major catalyst for new payment and delivery reform models such as ACOs

■ The shift in focus and incentives for providers in ACOs and bundled payment initiatives

■ The impact of ACOs and the new payment initiatives on the development of value propositions by the Life Sciences

ANDREW THORRENS, Head of Reimbursement and Market Access, DURATA THERAPEUTICS, INC.

1:45 Shifting Communication Approach’s: Understanding and Engaging with your Customers to Expand Partnership Buy-In

■ Understanding your customers: How ACOs see themselves and their mission

■ Exploring the cost savings and patient quality structures ACOs work in

■ Identifying ways to bring value to ACOs ■ Adjusting your support strategies to facilitate your

customers’ goals ■ Developing platforms in which you can demonstrate value

and develop collaborative partnerships that work for both industry and ACOs

LON CASTLE, Medical Science Liaison, CARDIODX

2:30 Navigating the Value-Based Healthcare Environment: Developing an Organization Wide Approach to Understand the Changing Healthcare Delivery System and our Customers

■ Understanding of ACOs and their impact on patient care ■ Developing and gathering market research to develop a fi rm

grasp of the ACO culture ■ Analyzing market research to develop strategies for enhancing

relationships with ACOs ■ Developing customer engagement platforms strategies focused

on strategic value collaboration

LAUREN WALRATH, Director, Business Model Innovation and Commercial Operations, BRISTOL-MYERS SQUIBB

3:15 CLOSING REMARKS

3:30 SUMMIT CONCLUDES

The ACO Relationship Board Room Dinner6:00-9:00 Developing ways to Collaborate and Supply the Healthcare Marketplace

With the rapid growth of ACOs and the increasing number of changes within healthcare system its clear that a traditional sales style will not work for ACOs. Instead, adapting a relationship style of partnering with your customers is now the preferred method, and is well received by ACO executives. By developing these sustainable relationships, manufactures will be able to develop a two-way dialogue where they can construct strategic platforms that will allow ACOs to improve quality, patient care, and improve a populations care.

Some of the most common strategies are designed because ACOs are in need of outcomes data, clinical services, affective diagnostic testing, laboratories services and patient adherence support. However as every ACO is constructed differently there is not one preferred platform to provide value. It’s important for you to understand how your customer is designed, functions, how patients are treated, and what value-add they are requiring.

This exclusive dinner will allow participants the chance to network and start the relationship process with ACOs. The pre-dinner interactive panel session will feature ACO executives discussing the following:

■ Overview of their organization ■ Structure of their ACO ■ Payment models ■ Value-add needs

BOARD ROOM DINNER LEADER: DAVID B. NASH, MD, MBA, Dean, JEFFERSON SCHOOL OF POPULATION HEALTH

ACOs PARTICIPATING INCLUDE:

For additional information go to EXLPHARMA.COM/ACO *Limited seats available

■ How industry can provide value to their ACO

■ Resources needed to execute a successful ACO

Atrius Health Brevard Physician Network Cooper University HospitalGoldenlife HealthcareFlorida Physicians Trust ACOsThe Hackensack Alliance Accountable Care Organization

Health Catalyst/TEAM of Care Solutions Hunterdon Healthcare PartnersMartin Health SystemSisters of Providence Health SystemsSummit Medical GroupWalgreensWest Florida ACO LLC

PRICING FOR THE 3RD PARTNERING WITH ACOs SUMMIT:

STANDARD PRICINGRegistering After January 31, 2014

Life Science/Service Providers

Summit & Board Room Dinner: $2695

Summit Only: $2095

ACOs, Health Plans/Systems, and Physician Organizations

Summit & Board Room Dinner: $1695

Summit Only: $1495

For cancellation policy and group rates please visit: http://www.exlpharma.com/event-pricing/4312* Includes sales tax and service fees.

TERMS & CONDITIONS:By registering for an ExL Events, Inc. (“ExL Pharma”) event, you agree to the following set of terms and conditions listed below:

REGISTRATION FEE:The fee includes the conference‚ all program materials‚ and designated continental breakfasts‚ lunches and refreshments.

Group Discount Program: save 25% per person when registering Four. For every three simultaneous registra-tions from your company, you will receive a fourth complimentary registration to the program (must register 4 at one time) this is a savings of 25% per person. save 15% per person when registering three. Can only send three? you can still save 15% off of every registration.

To fi nd out more on how you can take advantage of these group discounts, please call 866-207-6528.

PAYMENT:Must be received in full by the conference date. All discounts will be applied to the Conference Only fee (excluding add-ons)‚ cannot be combined with any other offer‚ and must be paid in full at the time of order. Group discounts available to individuals must be registered simultaneously and employed by the same organization.

Cancellation and Refund PolicyIf you need to cancel your registration for an upcoming ExL event, please note the following policies derived from the Start Date of the event:• Four weeks or more: A full refund (minus a $295 processing fee) or a voucher to another ExL event valid

for 18 months from the voucher issue date.• Less than four weeks: A voucher to another ExL event valid for 18 months from the voucher issue date If you cancel at any time after receiving the conference documentation, the voucher issued will be $395 less

Substitution Charges:There will be an administrative charge of $300 to substitute, exchange and/ or replace attendee badges with a colleague occurring within fi ve business days of the conference.

ExL Pharma reserves the right to cancel any conference it deems necessary and will not be responsible for airfare‚ hotel or any other costs incurred by registrants.

ExL Pharma’s liability is limited to the conference registration fee in the event of a cancellation and does not include changes in program date‚ content‚ speakers‚ or venue

* The opinions of ExL speakers do not necessarily refl ect those of the companies they represent, nor ExL Events, Inc.

Please Note: Speakers and agenda are subject to change without notice. In the event of a speaker cancellation, signifi cant effort to fi nd a suitable replacement will be made.

The content in ExL slide presentations, including news, data, advertisements and other information, is provided by ExL Events,

Inc.’s (“ExL’s”) designated speakers and is designed for informational purposes for its attendees, and is NOT INTENDED for

purposes of copywriting, nor redistribution to other outlets without the express written permission of ExL’s designated speaking

parties. Neither ExL, nor its content providers and/or speakers and attendees shall be liable for any errors, inaccuracies or delays in

content, or for any actions taken in reliance thereon. EXL EVENTS, INC. EXPRESSLY DISCLAIMS ALL WARRANTIES, EXPRESSED

OR IMPLIED, AS TO THE ACCURACY OF ANY THE CONTENT PROVIDED, OR AS TO THE FITNESS OF THE INFORMATION FOR

ANY PURPOSE. Although ExL makes reasonable efforts to obtain reliable content from third parties, ExL does not guarantee the

accuracy of or endorse the views or opinions given by any third party content provider. ExL presentations may point to other Inter-

net sites that may be of interest to you, however ExL does not endorse or take responsibility for the content on such other sites

Name: Title:

Company:

Dept:

Address:

City: State: Zip:

Email:

Phone: Fax:

Card Number: Exp. Date:

Name on Card:

Signature:

Method of Payment: □ Check □ Credit Card

Card Type: □ MasterCard □ Visa □ AMEX

REGISTRATIONto register CLICK HERE, or

Call: 201 871 0474fax: 253 663 7224Email: register@pmaconference.comMail: POB 2303 Falls Church, VA 22042Web: www.pmaconference.com/fda.htm

36OPMTHE FULL SPECTRUM OF PRODUCT MANAGEMENT

36O